Quick take - SeaStar Medical Holding Corporation (NASDAQ: LMAO)
SeaStar (LMAO) is transitioning from R&D to commercial stage after FDA HDE approval for its pediatric SCD (QUELIMMUNE). The company is showing early product revenue but remains loss-making, cash-constrained and faces shareholder/lega...